Solesence, Inc. (SLSN)
NASDAQ: SLSN · Real-Time Price · USD
1.370
-0.020 (-1.44%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States.

The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients.

It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products.

The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications.

It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025.

Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Solesence, Inc.
Solesence logo
Country United States
Founded 1989
Industry Household & Personal Products
Sector Consumer Staples
Employees 115
CEO Kevin Cureton

Contact Details

Address:
1319 Marquette Drive
Romeoville, Illinois 60446
United States
Phone 630 771 6708
Website solesence.com

Stock Details

Ticker Symbol SLSN
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000883107
ISIN Number US6300791018
Employer ID 36-3687863
SIC Code 2844

Key Executives

Name Position
Kevin Cureton President, Chief Executive Officer and Director
Laura Riffner Chief Financial Officer

Latest SEC Filings

Date Type Title
Apr 23, 2026 10-K/A [Amend] Annual report
Mar 31, 2026 10-K Annual Report
Mar 31, 2026 8-K Current Report
Dec 3, 2025 8-K Current Report
Dec 1, 2025 8-K Current Report
Nov 13, 2025 8-K Current Report
Nov 12, 2025 10-Q Quarterly Report
Nov 6, 2025 8-K Current Report
Sep 4, 2025 8-K Current Report
Aug 29, 2025 8-K Current Report